Clinical Trial Update: Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of Lucentis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating changes in optical coherence tomography parameters after intravitreal Lucentis (ranibizumab) injections for age-relat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Osias Francisco de Souza | Conditions: Degeneration of Macula and Posterior Pole | Phase 4 | Status: UNKNOWN